Tweet
Alzheimer's therapy flops in phase III clinical trial Science AAAS Swiss pharmaceutical giant Roche announced today it is ending a phase III clinical trial for the experimental drug gantenerumab, a monoclonal antibody therapy, because the drug has failed to actually help prevent Alzheimer's disease, Bloomberg reports. and more » |
More...